Clinical Trial

Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay. 1. Does a clinically relevant dose of commercially available activated charcoal raise the osmolal gap above the baseline of a healthy volunteer? 2. Does the same dose of charcoal cause a false positive enzymatic assay for ethylene glycol? Participants will be asked to consume a dose of activated charcoal and have serial blood draws for laboratory measurements.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-01
notable Primary completion pushed: 2026-05-01 -> 2026-07-31 2026-08-01
minor Completion pushed: 2026-05-01 -> 2026-07-31 2026-08-01
Trial Details
NCT Number NCT07220031
Lead Sponsor State University of New York - Upstate Medical University
Conditions Osmolality Disturbance, Lab Interference
Enrollment 8 participants
Start Date 2025-11-15
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-31